| Age (years) |
M ± SD |
67.1 ± 9.1 |
| Tumor |
Rank |
N (%) |
| T1 |
1 |
4 (6.3) |
| T2 |
2 |
14 (22.2) |
| T3 |
3 |
29 (46.0) |
| T3b |
4 |
3 (4.8) |
| T3d |
5 |
1 (1.6) |
| T4 |
6 |
6 (9.5) |
| T4a |
7 |
4 (6.3) |
| T4b |
8 |
2 (3.2) |
| Lymph node |
|
N (%) |
| N0 |
1 |
19 (30.2) |
| N1 |
2 |
3 (4.8) |
| N1a |
3 |
5 (7.9) |
| N1b |
4 |
8 (12.7) |
| N1c |
5 |
6 (9.5) |
| N2 |
6 |
6 (9.5) |
| N2a |
7 |
7 (11.1) |
| N2b |
8 |
9 (14.3) |
| Metastasis |
|
N (%) |
| M0 |
1 |
7 (11.1) |
| M1 |
2 |
24 (38.1) |
| M1a |
3 |
1 (1.6) |
| M1b |
4 |
3 (4.8) |
| M2 |
5 |
21 (33,3) |
| M3 |
6 |
7 (11.1) |
| Grading |
|
N (%) |
| 1 |
1 |
5 (7.9) |
| 2 |
2 |
47 (74.6) |
| 3 |
3 |
11 (17.5) |